AI
AGIO icon

Atria Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Atria Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
14,033
+156
+1% +$4.73K 0.01% 1492
2026
Q1 		$469K Sell
13,877
-176
-1% -$4.99K 0.01% 1484
2025
Q4 		$383K Buy
14,053
+667
+5% +$23.4K ﹤0.01% 1599
2025
Q3 		$537K Sell
13,386
-87
-0.6% -$3.27K 0.01% 1378
2025
Q2 		$448K Sell
13,473
-1,122
-8% -$34K 0.01% 1481
2025
Q1 		$428K Buy
14,595
+3,230
+28% +$107K 0.01% 1437
2024
Q4 		$373K Buy
11,365
+737
+7% +$34.6K ﹤0.01% 1470
2024
Q3 		$472K Buy
10,628
+3,418
+47% +$155K 0.01% 1358
2024
Q2 		$311K Buy
+7,210
New +$260K ﹤0.01% 1572

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Atria Investments's AGIO Position: Q2 2026 in Review

Atria Investments increased its Agios Pharmaceuticals (AGIO) stake by 1.1% in Q2 2026, buying an estimated $4.73K and bringing the position to 14,033 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #1492.

Atria Investments first reported a position in AGIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $537K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Atria Investments held 14,033 shares of Agios Pharmaceuticals worth $521K as of Q2 2026.
  • Atria Investments bought 156 Agios Pharmaceuticals shares in Q2 2026, an estimated $4.73K.
  • Agios Pharmaceuticals made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1492 holding.
  • Atria Investments first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's Agios Pharmaceuticals position peaked at $537K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.